Skip to main content

Part of the book series: Emerging Infectious Diseases of the 21st Century ((EIDC))

10. Summary

In this chapter, I have demonstrated that it is possible to calculate the optimal annual amount that should be spent on a defined intervention to prevent or reduce the impact of a bioterrorist attack or other catastrophic infectious disease event. Such calculations, however, are not trivial and require a great deal of information. The information includes the epidemiology of the disease (e.g., who gets ill, what happens to them), the cost of such impacts, the potential effectiveness of proposed interventions, and an understanding of the annual probability of the event actually occurring. There are a great number of uncertainties associated with each of these inputs, and the impact of such uncertainties must be explored through systematic sensitivity analyses. One of the goals of such sensitivity analyses should be to identify the 2–3 most influential inputs. These 2–3 influential inputs then represent potential “policy levers” that policy makers can focus interventions. Finally, it must be appreciated that calculating the optimal annual amount to be spent on an intervention is not the complete set of decision-making points. There are many other factors influencing the choice of intervention. However, because calculating the optimal amount to be spent on a given intervention combines many different variables into a single estimate (the optimal amount), the calculated amount provides valuable information by which to start the decision-making process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson, R.M., and May, R.M. (1991). Infectious Diseases of Humans. Oxford University Press, New York.

    Google Scholar 

  • Grosse, S.D. (2003). Productivity loss tables. Appendix I. In: Haddix, A.C., Teutsch, S.M., and Corso, P.S. (eds.), Prevention Effectiveness, 2nd ed. Oxford University Press, New York, pp. 245–257.

    Google Scholar 

  • Haddix, A.C., Corso, P.S., and Gorsky, R.D. (2003). Costs. In: Haddix, A.C., Teutsch, S.M., and Corso, P.S. (eds.), Prevention Effectiveness, 2nd ed. Oxford University Press, New York, pp. 53–76.

    Google Scholar 

  • Kaufman, A.F., Meltzer, M.I., and Schmid, G.P. (1997). The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis. 3:83–94.

    Google Scholar 

  • Koopman, J.S., Jacquez, G., and Chick, S.E. (2001). New data and tools for integrating discrete and continuous population modeling strategies. Ann. N.Y. Acad. Sci. 954:268–294.

    Article  PubMed  CAS  Google Scholar 

  • Meltzer, M.I., Cox, N.J., and Fukuda, K. (1999). The economics impact of pandemic influenza in the United States: priorities for intervention. Emerg. Infect. Dis. 5:659–671.

    Article  PubMed  CAS  Google Scholar 

  • Meltzer, M.I., Damon, I., LeDuc, J.W., and Millar, J.D. (2001). Modeling potential responses to smallpox as a bioterrorist weapon. Emerg. Infect. Dis. 7:959–969.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Meltzer, M.I. (2005). The Economics of Planning and Preparing for Bioterrorism. In: Fong, I.W., Alibek, K. (eds) Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century. Emerging Infectious Diseases of the 21st Century. Springer, Boston, MA. https://doi.org/10.1007/0-387-23685-6_10

Download citation

  • DOI: https://doi.org/10.1007/0-387-23685-6_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-23684-1

  • Online ISBN: 978-0-387-23685-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics